Pilot study of the [18F]THK-5351 positron emission tomography (PET) tracer in different tauopathies.
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2018
At a glance
- Drugs Fluorine 18 THK 5351 (Primary)
- Indications Tauopathies
- Focus Diagnostic use
- 31 Aug 2018 Status changed from recruiting to discontinued.
- 13 Oct 2017 New trial record